Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
GenomeMiner (formerly Tupac.Bio)
Onna, Japan
A
1-10 Employees
2015
Key takeaway
GenomeMiner focuses on leveraging bioinformatics for the sustainable production of natural products and the discovery of novel compounds, which aligns with the innovative potential of gene editing technologies. Their commitment to developing in-house assets like biofungicides and bioinsecticides underscores their dedication to advancing sustainable solutions.
Reference
Core business
home
Genesis Healthcare Co
Tokyo, Japan
A
11-50 Employees
2004
Key takeaway
Genesis Healthcare focuses on using genetic science to enhance health and wellness, positioning itself as a leader in genetics in Japan. Their commitment to genetic analysis and innovation in health tech underscores the importance of genetic testing in promoting a healthy society.
Reference
Core business
Genesis Healthcare: DNA Genetic testing for your health.
Genesis Healthcare's mission is to make a meaningful impact on people's health and wellness through genetic science and health tech.
AccuRna
Tokyo, Japan
A
1-10 Employees
2015
Key takeaway
AccuRna is focused on developing innovative drug delivery systems for nucleic acid therapeutics, including mRNA, which is relevant to gene editing approaches. Their commitment to advancing nucleic acid-based therapies aims to provide effective treatments for patients with challenging diseases.
Reference
Product
Technologies – AccuRna, Inc.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
AceRNA
Kyoto, Japan
A
1-10 Employees
2018
Key takeaway
The company is a biotech startup dedicated to creating innovative genetic therapies that specifically target disease-causing cells, aiming to minimize patient burden. They are exploring new treatments in collaboration with partner companies, utilizing RNA switches to advance the future of targeted medicine.
Reference
Core business
News - aceRNA
aceRNA
ThinkCyte
Tokyo, Japan
A
11-50 Employees
2016
Key takeaway
The company is focused on advancing biology and medicine through innovative therapies and diagnostics, particularly in drug discovery and functional genomics. Their proprietary machine vision-based cell sorting technology enhances high-throughput screening methods, making it compatible with various libraries, including CRISPR, which is directly relevant to gene editing.
Reference
Product
Drug Discovery - ThinkCyte
Pooled High-Content Screening of Genes and Drugs Our Solution for Drug Discovery Image-based high-content screening (HCS) is a powerful method for identifying genes compounds that induce physiologically relevant disease-linked cellular phenotypes. However, it is time-consuming expensive due to its reliance on well-to-well imaging of microplates. Using ThinkCyte’s proprietary machine Vision-based Cell Sorting technology, we have developed a new method that enables high-throughput image-based HCS in a pooled format. This novel method is compatible with various types of libraries, including CRISPR gRNAs, shRNAs, antibodies, peptides, small molecule compounds. From array to pool Key Advantages of Our Technology Compatible with a wide range of libraries Small molecule libraries, CRISPR, shRNA, peptide, phage … Continued
ReproCELL
Yokohama, Japan
A
51-100 Employees
2003
Key takeaway
REPROCELL specializes in translational research, offering a wide array of products and services that support stem cell research and the development of regenerative medicine therapies. Their expertise in induced pluripotent stem cells (iPSCs) and ongoing clinical trials for neurodegenerative diseases highlights their commitment to advancing therapeutic innovations.
Reference
Product
Products: RNA Reprogramming
Looking for RNA Reprogramming kits? Browse a range of footprint-free reprogramming kits from Stemgent on the REPROCELL website.
Genomedia
Tokyo, Japan
A
1-10 Employees
2013
Key takeaway
Genomedia Inc. offers genome information analysis services, which may be relevant to the field of gene editing.
Reference
Service
SERVICE – Genomedia
Molcure
Tokyo, Japan
A
11-50 Employees
2013
Key takeaway
The company utilizes advanced AI technology and proprietary methods to analyze over 1 billion biopharmaceutical data points, focusing on the identification of valuable antibodies and peptides. Their approach includes directed evolution experiments and machine learning models to predict essential biopharmaceutical properties.
Reference
Core business
Molcure Inc. | Accelerating drug discovery
GENEX
Tokyo, Japan
A
- Employees
2019
Key takeaway
The company highlights its whole-genome management service, which aids in identifying new causative genes, a crucial aspect of gene editing and drug discovery. Their compliance with ethical guidelines ensures that their practices align with current standards in medical and biological research.
Reference
Service
希少疾患への取り組み | ジーネックス株式会社
T Cell Nouveau
Tokyo, Japan
A
1-10 Employees
2021
Key takeaway
T Cell Nouveau Inc. is advancing gene editing through its innovative Hybrid CAR T-cell therapy, which represents a significant breakthrough in treating solid tumors. This approach builds on the foundation of modern CAR/TCR-T cell therapies, showcasing the company's commitment to cancer immunotherapeutics.
Reference
Product
Technology | T Cell Nouveau Inc.
CAR-T細胞治療 自己由来CAR-T細胞治療
Technologies which have been searched by others and may be interesting for you:
The gene editing industry in Japan is influenced by several key considerations that potential investors or researchers should be aware of. Regulatory frameworks in Japan are stringent, especially concerning ethical guidelines surrounding genetic modifications. Understanding the legal landscape, including the guidelines set by the Japanese government and the Ministry of Health, Labour and Welfare, is crucial for navigating the industry. Challenges such as public perception and ethical debates may also impact research and development efforts. Opportunities abound, particularly in agricultural biotechnology and healthcare, where gene editing can drive innovation. Japanese companies are increasingly collaborating with international firms, enhancing their global competitiveness. Environmental concerns are significant, especially regarding the impact of genetically modified organisms (GMOs) on biodiversity and ecosystems, necessitating careful consideration of sustainability practices. The competitive landscape includes a mix of established biotech firms and startups, with a growing emphasis on CRISPR technology and its applications. As Japan seeks to bolster its position in the global market, advancements in gene editing could play a vital role in addressing health and food security challenges. Researchers and businesses must stay informed about both domestic and international trends to effectively engage in this evolving field.
Some interesting numbers and facts about your company results for Gene Editing
| Country with most fitting companies | Japan |
| Amount of fitting manufacturers | 27 |
| Amount of suitable service providers | 15 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2003 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Gene Editing
What are related technologies to Gene Editing?
Based on our calculations related technologies to Gene Editing are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Gene Editing?
Start-Ups who are working in Gene Editing are T Cell Nouveau
Which industries are mostly working on Gene Editing?
The most represented industries which are working in Gene Editing are Other, Biotechnology, IT, Software and Services, Marketing Services, Finance and Insurance
How does ensun find these Gene Editing Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.